Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study

NCT04789018 | Active Not Recruiting

• 3 other identifiers: 20F.936JT 16041080-27000-X17501
• Study Type: observational
• Target: 118
• Locations: 1 country
• Sites: 1

Brief Summary

This study assesses perceived usefulness of a web-based virtual prostate cancer genetics board for providers across academic, community, and veteran affairs settings to discuss prostate cancer genetics cases, precision treatment, and screening recommendation. Information gained from interviews and surveys of participants taking part in the virtual genetics board may lend insights into perceived usefulness, perceived ease of use, acceptability, self-efficacy, genetics knowledge, and barriers/facilitators to implementation to refine the process.

Conditions

Prostate Carcinoma

Outcome Measures

Primary Outcomes (1)

• Mean Likert scaled perceived usefulness scores of the virtual genetics board

  Perceived usefulness will be judged against a benchmark mean score of 5/7.

  After virtual genetics board

Secondary Outcomes (4)

• Means or changes in means of Likert scaled acceptability/feasibility

  Before and after virtual genetics board

• Perceived ease of use

  After virtual genetics board

• Self-efficacy for recommendations

  Before and after virtual genetics board

• Change in mean scores on 17 genetics knowledge test questions

  Baseline up to post-virtual genetics board

Study Arms (1)

Observational (survey, virtual genetic board, interview)

Participants complete a survey about genetic knowledge and self efficacy and then attend virtual genetics board. After virtual genetics board meeting, participants complete a second survey about perceived usefulness, ease of use, acceptability, feasibility, self-efficacy and genetic knowledge. Participants may also complete a semi-structured interview after virtual genetics board.

Other: Educational Intervention; Other: Survey Administration; Other: Interview

Interventions

Educational Intervention OTHER

Attend virtual genetics board

Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational

Observational (survey, virtual genetic board, interview)

Survey Administration OTHER

Complete survey

Observational (survey, virtual genetic board, interview)

Interview OTHER

Complete interview

Observational (survey, virtual genetic board, interview)

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Non-genetic providers who perform prostate cancer (PCA) genetic testing for men in their practices (medical oncologists, radiation oncologists, urologists, primary care providers, mid-level providers)

You may qualify if:

• Healthcare providers (medical oncologists, radiation oncologists, urologists, primary care providers, mid-level providers) who evaluate, manage, or treat men with prostate cancer or screen men for prostate cancer.
• Providers who perform prostate cancer genetic testing for men (genetic counselors or healthcare providers)
• Scientists and researchers
• Advocacy or patient stakeholder organization members

You may not qualify if:

• Non-medical providers

Sponsors & Collaborators

• Thomas Jefferson University: lead

Study Sites (1)

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Early Intervention, Educational; Educational Status; Methods; Interviews as Topic

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Intervention Hierarchy (Ancestors)

Child Health Services; Community Health Services; Health Services; Health Care Facilities Workforce and Services; Preventive Health Services; Socioeconomic Factors; Population Characteristics; Investigative Techniques; Data Collection; Epidemiologic Methods; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Amy Leader, DrPH, MPH

  Thomas Jefferson University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 19, 2021
• First Posted: March 9, 2021
• Study Start: January 21, 2020
• Primary Completion (Estimated): June 24, 2026
• Study Completion (Estimated): June 24, 2026
• Last Updated: October 10, 2025

Record last verified: 2025-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)